Tardive dystonia induced by atypical neuroleptics:: A case report with olanzapine

被引:21
作者
Charfi, F
Cohen, D
Houeto, JL
Soubrié, C
Mazet, P
机构
[1] Dept Psychiat Enfant & Adolescent, Paris, France
[2] Federat Neurol, Paris, France
[3] Serv Pharmacol, Paris, France
关键词
D O I
10.1089/104454604773840607
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We report the case of a 17-year-old-boy with schizophrenia who developed tardive dystonia after 9 months of treatment with olanzapine. This case and the relevant literature show that when neuroleptic treatment is indicated, switching to another atypical neuroleptic might be helpful for both tardive dystonia and schizophrenia. In such a case, clozapine appears to be the first-line therapeutic option.
引用
收藏
页码:149 / 152
页数:4
相关论文
共 21 条
[1]   TARDIVE DYSTONIA - LATE-ONSET AND PERSISTENT DYSTONIA CAUSED BY ANTI-PSYCHOTIC DRUGS [J].
BURKE, RE ;
FAHN, S ;
JANKOVIC, J ;
MARSDEN, CD ;
LANG, AE ;
GOLLOMP, S ;
ILSON, J .
NEUROLOGY, 1982, 32 (12) :1335-1346
[2]   Risperidone treatment of tardive dyskinesia and dystonia [J].
Chong, SA ;
Remington, G ;
Tan, CH .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (05) :340-341
[3]   Olanzapine-induced tardive dystonia [J].
Dunayevich, E ;
Strakowski, SM .
AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (10) :1662-1662
[4]   Tardive dystonia associated with olanzapine therapy [J].
Gunal, DI ;
Onultan, O ;
Afsar, N ;
Aktan, S .
NEUROLOGICAL SCIENCES, 2001, 22 (04) :331-332
[5]   Thalamotomy for severe antipsychotic induced tardive dyskinesia and dystonia [J].
Hillier, CEM ;
Wiles, CM ;
Simpson, BA .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02) :250-251
[6]  
Jaffe ME, 1999, AM J PSYCHIAT, V156, P2016
[7]   The natural history of tardive dystonia - A long-term follow-up study of 107 cases [J].
Kiriakakis, V ;
Bhatia, KP ;
Quinn, NP ;
Marsden, CD .
BRAIN, 1998, 121 :2053-2066
[8]  
Krebs MO, 1999, CAN J PSYCHIAT, V44, P507
[9]   Treatment of patients with tardive dystonia with olanzapine [J].
Lucetti, C ;
Bellini, G ;
Nuti, A ;
Bernardini, S ;
Dell'Agnello, G ;
Piccinni, A ;
Maggi, L ;
Manca, L ;
Bonuccelli, U .
CLINICAL NEUROPHARMACOLOGY, 2002, 25 (02) :71-74
[10]  
Molho ES, 1999, MOVEMENT DISORD, V14, P873, DOI 10.1002/1531-8257(199909)14:5<873::AID-MDS1027>3.0.CO